drugset / Trial / NCT00343096

Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children.

NCT00343096

Phase 3 Terminated 800 enrolled Kamuzu University of Health Sciences
RandomizedFactorialOpen-labelTreatment

Summary

This study aims to address the hypothesis that Lorazepam (an anticonvulsant) is as effective when given via the intranasal or buccal route as the intravenous route in terminating convulsions in children.

Timeline

Start
2006-06
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lorazepam Small molecule 0.1 mg/kg Intranasal

Indications